Analyzing Swimming Pool Water
Pharmaceutical and personal care products (PPCPs) entering water supplies have been widely studied, but there is little information on the activity of these compounds in swimming pool water. Researchers have applied a PPCP analysis method previously developed for the detection of 32 PPCPs in wastewater to survey indoor swimming pools in the USA.
Pharmaceutical and personal care products (PPCPs) entering water supplies have been widely studied, but there is little information on the activity of these compounds in swimming pool water. Researchers have applied a PPCP analysis method previously developed for the detection of 32 PPCPs in wastewater to survey indoor swimming pools in the USA.1,2
Water samples were taken from three swimming pools in Indiana and Georgia in the USA during the winter of January 2013 and the summer of July 2014. Samples were extracted using solid-phase extraction (SPE) and subsequently analyzed using liquid chromatography tandem mass spectrometry (LC–MS–MS). N,N-diethyl-m-toluamide (DEET), caffeine, and tri(2-chloroethyl)- phosphate (TCEP) were detected at measurable concentrations. Corresponding author Ernest R. Blatchley III told The Column: “From my perspective, our results to date do not represent any cause for alarm. We did find three PPCPs (out of roughly 30 that are identif able and quantif able using Professor Huang’s LC–MS–MS method), but we do not have enough information to address the importance of these data with respect to human health. Moreover, we have essentially no information about the other PPCP compounds (or their derivatives) that could be present in pools.” - B.D.
References
1. S. Weng, P. Sun, W. Ben, C-H. Huang, L.T. Lee, and E.R. Blatchley III, Environmental Science and Technology Letters1, 495−498 dx.doi. org/10.1021/ez5003133 (2014).
2. L.P. Padhye, H. Yao, F.T. Kung’u, and C-H. Huang, Water Research DOI: 10.1016/j.watres.2013.10.070 (2014).
This article is from The Column. The full issue can be found here>>
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
